Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: The Effect of Milk Thistle on the Pharmacokinetics of Indinavir [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated whether milk thistle alters the pharmacokinetics of the HIV drug indinavir in healthy volunteers and/or individuals with HIV infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crixivan (indinavir)
  • Milk Thistle (silymarin)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: HIV Infection, Healthy | Phase 1 | Status: COMPLETED